These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 311004)

  • 1. Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
    Mitchell BS; Mejias E; Daddona PE; Kelley WN
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5011-4. PubMed ID: 311004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
    Carson DA; Kaye J; Matsumoto S; Seegmiller JE; Thompson L
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2430-3. PubMed ID: 313056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine deoxyribonucleosides counteract effects of hydroxyurea on deoxyribonucleoside triphosphate pools and DNA synthesis.
    Lagergren J; Reichard P
    Biochem Pharmacol; 1987 Sep; 36(18):2985-91. PubMed ID: 3498491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
    Dahbo Y; Eriksson S
    Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppressive agents on human T and B lymphoblasts.
    Kazmers IS; Daddona PE; Dalke AP; Kelley WN
    Biochem Pharmacol; 1983 Mar; 32(5):805-10. PubMed ID: 6404281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.
    Sidi Y; Mitchell BS
    J Clin Invest; 1984 Nov; 74(5):1640-8. PubMed ID: 6334099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of purine metabolism in lymphocytes.
    Henderson JF; Smith CM; Zombor G
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):419-26. PubMed ID: 3875099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
    Scharenberg JG; Spaapen LJ; Rijkers GT; Wadman SK; Staal GE; Zegers BJ
    Adv Exp Med Biol; 1986; 195 Pt B():191-9. PubMed ID: 3094325
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodeficiencies associated with errors in purine metabolism.
    Edwards NL
    Med Clin North Am; 1985 May; 69(3):505-18. PubMed ID: 3925260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
    Mitchell BS; Edwards NL
    J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
    J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.